|  |  | No-matched cohort | Matched cohort | ||||
---|---|---|---|---|---|---|---|---|
Variables |  | n = 732 | AT (n = 64) | Non-AT (n = 668) | p value | AT (n = 63) | Non-AT (n = 63) | p value |
Laparoscopic surgery | Present | 402 (55%) | 14 (22%) | 338 (58%) |  < 0.001 | 14 (22%) | 17 (27%) | 0.501 |
Energy device | Present | 395 (53%) | 26 (41%) | 369 (55%) | 0.025 | 25 (40%) | 25 (40%) | 1.000 |
Operating time* | min | 94 (71–124) | 100 (62–128) | 93.5 (71–124) | 0.927 | 101 (62–129) | 99 (74–131) | 0.955 |
Estimated blood loss* | mL | 10 (2–70) | 40.5 (10–307) | 8 (2–61) |  < 0.001 | 36 (10–299) | 53 (5–251) | 0.466 |
Intra- and postoperative blood transfusion | Present | 1 (0.2%) | 11 (17%) | 25 (4%) |  < 0.001 | 11 (17%) | 7 (11%) | 0.309 |
Overall complications | Present | 61 (8.3%) | 21 (22%) | 40 (6.0%) |  < 0.001 | 14 (27%) | 16 (25%) | 0.676 |
Bleeding | Present | 8 (1.1%) | 3 (4.7%) | 5 (0.75%) | 0.025 | 0 | 2 (3.2%) | 0.094 |
Stroke | Present | 3 (0.4%) | 3 (0.5%) | 0 | 0.458 | 1 (1.6%) | 0 | 0.238 |
Pulmonary | Present | 12 (1.6%) | 4 (6.3%) | 8 (1.2%) | 0.016 | 2 (3.2%) | 3 (4.8%) | 0.647 |
Renal/urological | Present | 7 (1.0%) | 1 (1.6%) | 6 (0.9%) | 0.630 | 2 (3.2%) | 0 | 0.094 |
Surgical site infection | Present | 29 (3.7%) | 5 (7.8%) | 24 (3.6%) | 0.138 | 7 (11.1%) | 5 (7.9%) | 0.543 |
Anastomotic failure | Present | 4 (0.5%) | 1 (1.6%) | 3 (0.5%) | 0.335 | 2 (3.2%) | 1 (1.6%) | 0.555 |
Death within 30Â days after surgery | Present | 17 (2.3%) | 5 (7.8%) | 12 (1.8%) | 0.013 | 3 (4.8%) | 4 (6.3%) | 0.697 |
Hospital stay after surgery* | Days | 5 (4–10) | 13 (9–22) | 5 (4–9) |  < 0.001 | 13 (9–22) | 10 (7 -20) | 0.409 |
Hospital death | Present | 25 (3.4%) | 6 (9.4%) | 19 (2.8%) | 0.020 | 5 (8%) | 6 (10%) | 0.752 |